Celgene halts phase III trial of cancer drug Revlimid
New Zealand | Regulatory | By BioSpectrum Bureau | 2 Comment | 19 Jul, 2013
Singapore: Celgene has discontinued treatment with Revlimid (lenalidomide), prescribed for for multiple myeloma, in open...Read more
Connected care' is the new mantra of APAC healthcare
New Zealand | Opinion | By BioSpectrum Bureau | 1 Comment | 29 Aug, 2013
Health systems around the Asia-Pacific region and beyond are under pressure from the increasing demands of an aging po...Read more
NZ, Aus govt commit $2.5 mn for rheumatic vaccine
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 22 Feb, 2013
Singapore: The decision by New Zealand and Australian Prime Ministers to investigate potential vaccines against rheumati...Read more
Mylan to develop, market Biocon generic insulin
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 14 Feb, 2013
Bangalore: India's No 2 biotech company, Bangalore-based Biocon has announced a strategic partnership with global generi...Read more
Transplant pig cells into human brain to treat Parkinson's
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 19 Nov, 2012
Singapore: Living Cell Technologies (LCT) has received ethical approval from the New Zealand Ministry of Health's Healt...Read more
BioSpectrum Asia launches 5th CRO survey
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 30 Jul, 2013
Singapore: After four consecutive successful annual surveys on the developments in the clinical research industry, BioSp...Read more
Largest NZ drug maker to remain a family business
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 30 Nov, 2012
Singapore: Douglas Pharmaceuticals, New Zealand's largest pharmaceutical manufacturer, will continue to remain a family...Read more
Nottingham university gets $25 mn for synthetic biology research
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 15 Nov, 2012
Singapore: The University of Nottingham has been awarded funding of $4.5 million (£2.9 million) to help make low-carbo...Read more
LCT conducts first implant of regenerative therapy
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 20 Sep, 2013
Singapore: Australia-based Living Cell Technologies (LCT) has implanted regenerative cell therapy NTCELL, a treatment fo...Read more
Dr Paul Hutchison: NZ's R&D investment is below OECD's average
New Zealand | Influencers | By BioSpectrum Bureau | 3 Comment | 20 Nov, 2012
Dr Paul Hutchison, a healthcare professional and a parliamentarian from Hunua, New Zealand, has emerged as one-of-the-mo...Read more
What functional roles do CROs play in APAC?
New Zealand | Analysis | By BioSpectrum Bureau | 2 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...Read more
Fisher & Paykel records profit of $62.40 mn
New Zealand | Company results | By BioSpectrum Bureau | 0 Comment | 23 May, 2013
Singapore: Fisher & Paykel Healthcare reported record net profit after tax of $62.40 million (NZ$77.1 million) for t...Read more
WHO aims to eliminate TB by 2050
New Zealand | Analysis | By BioSpectrum Bureau | 0 Comment | 08 Jul, 2014
Singapore: WHO along with European Respiratory Society (ERS), has outlined a framework to work on pre-elimination of tub...Read more
BSA-CMR Survey: New CRO players emerge in APAC
New Zealand | Analysis | By BioSpectrum Bureau | 2 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...Read more
Pictor offers multiple diagnosis with one drop of blood
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 23 Oct, 2012
New Zealand-based Dr Sarita Kumble and Dr Anand Kumble wanted to create an affordable diagnostic test platform that coul...Read more
ImmusanT starts trials of celiac disease vaccine, Nexvax2
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 05 Sep, 2012
Singapore: ImmusanT initiated clinical trials in New Zealand, Australia and the US to evaluate Nexvax2, the first thera...Read more
New Zealand's Biomatters wins Microsoft award
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 15 May, 2012
Singapore: Biomatters, which is known for developing the Geneious Pro, won the Microsoft Hi-Tech Emerging Company Award ...Read more
LanzaTech adds oil and gas veteran to its board
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 12 Mar, 2013
Singapore: LanzaTech, a producer of low-carbon fuels and chemicals from carbon-containing gases, appointed of Datuk Ir ...Read more